Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide/dexamethasone vs melphalan/prednisone as first-line therapy in multiple myeloma
2004-001426-24Phase 3Completed
- Sponsor
- Prof. Heinz Ludwig, MD, Wilhelminenspital, First Department of Medicine and Medical Oncology
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of thalidomide in multiple myeloma (MM) (4 arms), sponsored by Prof. Heinz Ludwig, MD, Wilhelminenspital, First Department of Medicine and Medical Oncology. Primary endpoint: Time to progression. Started Aug 2004; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2004-001426-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001426-24.